Interleukin (IL)-17A is involved in mucocutaneous defense [1] and plays a critical role in the pathogenesis of a range of immune-mediated diseases, including psoriasis (PsO), psoriatic arthritis (PsA), and ankylosing spondylitis (AS) [2–4]. Here, IL17A is linked to psoriatic arthritis.